Kathleen M Powis

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana
    Kathleen M Powis
    Department of Internal Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    J Acquir Immune Defic Syndr 62:517-24. 2013
  2. pmc Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana
    Kathleen M Powis
    Department of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, MA, USA
    J Acquir Immune Defic Syndr 56:131-8. 2011
  3. pmc Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy
    Kathleen M Powis
    Departments of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Infect Dis 204:506-14. 2011
  4. pmc Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants
    Scott Dryden-Peterson
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, United States of America Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 8:e74171. 2013
  5. pmc Single-Arm Evaluation of the AccuCirc Device for Early Infant Male Circumcision in Botswana
    Rebeca M Plank
    Division of Infectious Diseases, Department of Medicine, Brigham and Women s Hospital, Boston, MA Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA Botswana Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education, Gaborone, Botswana Department of Epidemiology, Harvard School of Public Health, Boston, MA Northern Inter Tribal Health Authority, Prince Albert, Saskatchewan, Canada Botswana Ministry of Health, Gaborne, Botswana Departments of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, MA and Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA
    J Acquir Immune Defic Syndr 66:1-6. 2014

Detail Information

Publications5

  1. pmc High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana
    Kathleen M Powis
    Department of Internal Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    J Acquir Immune Defic Syndr 62:517-24. 2013
    ..Systemic angiogenic imbalance contributes to preeclampsia in HIV-uninfected women, but changes in angiogenic markers after highly active antiretroviral therapy (HAART) initiation have not been studied...
  2. pmc Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana
    Kathleen M Powis
    Department of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, MA, USA
    J Acquir Immune Defic Syndr 56:131-8. 2011
    ..The impact of in utero exposure to highly active antiretroviral therapy (HAART) on longitudinal growth of HIV-uninfected infants is unknown...
  3. pmc Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy
    Kathleen M Powis
    Departments of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Infect Dis 204:506-14. 2011
    ..Protease inhibitor (PI)-based highly active antiretroviral therapy (HAART) use in pregnancy has been associated with preterm deliveries in some observational studies...
  4. pmc Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants
    Scott Dryden-Peterson
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, United States of America Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 8:e74171. 2013
    ..Prophylactic cotrimoxazole is recommended for infants born to HIV-infected mothers. However, cotrimoxazole may increase the risk of severe anemia or neutropenia...
  5. pmc Single-Arm Evaluation of the AccuCirc Device for Early Infant Male Circumcision in Botswana
    Rebeca M Plank
    Division of Infectious Diseases, Department of Medicine, Brigham and Women s Hospital, Boston, MA Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA Botswana Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education, Gaborone, Botswana Department of Epidemiology, Harvard School of Public Health, Boston, MA Northern Inter Tribal Health Authority, Prince Albert, Saskatchewan, Canada Botswana Ministry of Health, Gaborne, Botswana Departments of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, MA and Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA
    J Acquir Immune Defic Syndr 66:1-6. 2014
    ..In our study, the AccuCirc was safe and it should be considered for programmatic EIMC in resource-limited settings. ..